Bharat Biotech's indigenous COVID-19 vaccine 'COVAXIN' gets approval for phase I & II human clinical trials

Credit: DNA- Published 2 weeks ago
The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech. The indigenous inactivated vaccine was developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) High Containment facility located in Genome Valley, Hyderabad.

Video credit: Oneindia
Published 2 weeks ago -  02:34
Covid vaccine race| India puts 2 to human trials: Where do we stand? | Oneindia News
India's Covaxin has entered clinical trials while the Drug controller Genral of India gave the nod for another vaccine by Zydus Cadila for phase I and II human trials. ICMR has asked Bharat Biotech to fast-track vaccine trials keeping a roll-out date of August 15th in mind. With 2 vaccines in the race, how is India placed globally? #IndiaVaccine #Covid #Covaxin

You are here

Related videos from verified sources

Possible COVID-19 Vaccine Shown To Induce Strong Immune Response 00:32
Credit: Wochit Business - Published 3 hours ago 


Early Trials For Coronavirus Vaccine Show "Promise" 00:42
Credit: Wochit Business - Published 9 hours ago 


Bio-Tech Company Moderna To Begin Final Phase Of COVID-19 Vaccine Testing 00:28
Credit: CBS 2 New York - Published 19 hours ago 


Related news from verified sources

Indiaโ€™s first Covid-19 vaccine candidate Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the National Institute of Virology (NIV),...
2 weeks ago • IndiaTimes

You might like